Modest Effects of Valacyclovir in Herpes Zoster Eye Disease
TOPLINE: Low-dose suppressive valacyclovir treatment of herpes zoster ophthalmicus (HZO) did not show significant benefits at 12 months but showed treatment superiority at 18 months and a reduction in the number of multiple episodes of keratitis or iritis at 12 and 18 months. METHODOLOGY: Researchers conducted a placebo-controlled randomized clinical trial across 95 sites in … Read more